Safety, Efficacy, and PK of Topical Paromomycin/Gentamicin Cream for Treatment of Cutaneous Leishmaniasis
Status:
Terminated
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
The objectives of the study are to evaluate the safety, pharmacokinetics (PK), and efficacy
of open label treatment with WR 279,396 (Topical Paromomycin/Gentamicin Cream)in subjects
with cutaneous leishmaniasis (CL).
Phase:
Phase 2
Details
Lead Sponsor:
U.S. Army Medical Research and Development Command U.S. Army Medical Research and Materiel Command
Collaborators:
Walter Reed Army Institute of Research (WRAIR) Walter Reed National Military Medical Center